Atara Biotherapeutics (ATRA) PT Lowered to $4.80 at Stifel
Tweet
Share
E-mailGet Alerts ATRA Hot Sheet
Price: $8.90 --0%
Rating Summary:
5 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 4 | New: 18
Rating Summary:
5 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 4 | New: 18
Join SI Premium – FREE
Stifel analyst Benjamin Burnett lowered the price target on Atara Biotherapeutics (NASDAQ: ATRA) to $4.80 (from $4.90) while maintaining a Hold rating.
You May Also Be Interested In
- Kepler Cheuvreux Upgrades Entain PLC (ENT:LN) (GMVHF) to Buy
- Toyo Suisan Kaisha Ltd. (2875:JP) (TSUKF) PT Raised to JPY13,400 at JPMorgan
- Tyro Payments Limited (TYR:AU) (TYPMF) PT Lowered to AUD1.05 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
